Rifampicin
Rifampicin is a pharmaceutical drug with 113 clinical trials. Currently 8 active trials ongoing. Historical success rate of 94.3%.
Success Metrics
Based on 83 completed trials
Phase Distribution
Phase Distribution
68
Early Stage
17
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.3%
83 of 88 finished
5.7%
5 ended early
8
trials recruiting
113
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Clinical Trials (113)
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus
A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
PanACEA - STEP2C -01
Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects
Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects
Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects
A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects
1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 113